2011
DOI: 10.1016/j.jad.2010.08.009
|View full text |Cite
|
Sign up to set email alerts
|

The functional Val158Met polymorphism in catechol-O-methyltransferase (COMT) is associated with depression and motivation in men from a Swedish population-based study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
46
2

Year Published

2011
2011
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 69 publications
(51 citation statements)
references
References 83 publications
3
46
2
Order By: Relevance
“…There is some clinical evidence of increased COMT levels in depressed patients [72]. Moreover, there is evidence for genetic variations in the COMT gene that could lead to abnormal COMT function [73]. The COMT inhibitor tolcapone has been used clinically in Parkinson's patients to effectively treat their effort-related depressive symptoms [45].…”
Section: Discussionmentioning
confidence: 99%
“…There is some clinical evidence of increased COMT levels in depressed patients [72]. Moreover, there is evidence for genetic variations in the COMT gene that could lead to abnormal COMT function [73]. The COMT inhibitor tolcapone has been used clinically in Parkinson's patients to effectively treat their effort-related depressive symptoms [45].…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, such individuals are at higher risk to develop mental illnesses (Hosák 2007; Kocabas et al 2010; Witte and Flöel 2012; Baumann et al 2013). Men with this Met 158 variant were found to be more at risk for depression, displayed lower motivational levels and this risk increased in combination with a problematic childhood (Åberg et al 2011). In another study the trait-anger was found to be significantly associated with both low cooperativeness and depression (Balsamo 2013).…”
Section: Discussionmentioning
confidence: 99%
“…Conversely, the COMT Met allele has been associated with heightened scores of negative emotionality measured with selfreports (Lang et al 2007 ;Reuter & Hennig, 2005 ;Stein et al 2005), although inconsistent findings exist (Wray et al 2008). In addition, Met allele carriers show an increased proneness for the development of anxiety disorders (Enoch et al 2003 ;Olsson et al 2005 ;Woo et al 2004) and depression (Aberg et al 2011). Psychophysiological studies support these findings : the Met allele resulted in elevated startle responses (Armbruster et al 2011 ;Montag et al 2008) and in increased limbic and prefrontal activation in response to negative stimuli in functional magnetic resonance imaging (fMRI) studies (Drabant et al 2006 ;Rasch et al 2010 ;Smolka et al 2005 ;Williams et al 2010).…”
Section: Introductionmentioning
confidence: 91%